Last reviewed · How we verify
Maraviroc Switch Vascular Endothelium (VE) Substudy: a Substudy of MARCH (MARCH VE)
This is a substudy of MARCH, in which we are exploring the changes in the vascular endothelium using pulse wave tonometry (a non invasive measure of cardiac health) to measure the changes in small and large arterial elasticity in participants of the MARCH study who switch to maraviroc-based regimens over 96 weeks of follow-up.
Details
| Lead sponsor | Kirby Institute |
|---|---|
| Status | COMPLETED |
| Enrolment | 34 |
| Start date | 2012-06 |
| Completion | 2015-12 |
Conditions
- Cardiovascular Disease
Interventions
- NRTI + PI
- maraviroc + PI
- maraviroc + NRTI
Primary outcomes
- Mean change in small arterial elasticity (SAE) as measure by pulse wave tonometry — 96 weeks
measured at 6 timepoints week 0, 4, 12, 24, 48, 96
Countries
Argentina, Australia, Germany, Thailand